Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy M Mars

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|July 23, 2018
Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal MiceAnastasia Tsagianni, Wendy M Mars, Bharat Bhushan, et al.
The American Journal of Pathology|May 12, 2026
Hepatocyte-specific PPARγ Deletion Uncovers Role of an Antagonistic PPARγ-HNF4α Transcriptional Axis in MASLD ProgressionShehnaz Bano, Matthew A Copeland, Jia-Jun Liu, et al.
The American Journal of Pathology|April 15, 2020
Phosphorylated Ezrin (Thr567) Regulates Hippo Pathway and Yes-Associated Protein (Yap) in LiverYuhua Xue, Bharat Bhushan, Wendy M Mars, et al.
Hepatology (Baltimore, Md.)|August 15, 2020
Yes-Associated Protein Is Crucial for Constitutive Androstane Receptor-Driven Hepatocyte Proliferation But Not for Induction of Drug Metabolism Genes in MiceBharat Bhushan, Laura Molina, Kelly Koral, et al.
Hepatology (Baltimore, Md.)|July 12, 2016
Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensationShirish Paranjpe, William C Bowen, Wendy M Mars, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinaseUdayan Apte, Vasiliki Gkretsi, William C Bowen, et al.
Hepatology (Baltimore, Md.)|May 17, 2011
Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic miceChih-Wen Lin, Wendy M Mars, Shirish Paranjpe, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzeneShashikiran Donthamsetty, Vishakha S Bhave, Corrine S Kliment, et al.
Hepatology (Baltimore, Md.)|July 19, 2005
The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shockClaudio E Lagoa, Yoram Vodovotz, Donna B Stolz, et al.
The American Journal of Pathology|May 6, 2019
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced DiabetesGina M Coudriet, John Stoops, Anne V Orr, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|July 23, 2018
Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal MiceAnastasia Tsagianni, Wendy M Mars, Bharat Bhushan, et al.
The American Journal of Pathology|May 12, 2026
Hepatocyte-specific PPARγ Deletion Uncovers Role of an Antagonistic PPARγ-HNF4α Transcriptional Axis in MASLD ProgressionShehnaz Bano, Matthew A Copeland, Jia-Jun Liu, et al.
The American Journal of Pathology|April 15, 2020
Phosphorylated Ezrin (Thr567) Regulates Hippo Pathway and Yes-Associated Protein (Yap) in LiverYuhua Xue, Bharat Bhushan, Wendy M Mars, et al.
Hepatology (Baltimore, Md.)|August 15, 2020
Yes-Associated Protein Is Crucial for Constitutive Androstane Receptor-Driven Hepatocyte Proliferation But Not for Induction of Drug Metabolism Genes in MiceBharat Bhushan, Laura Molina, Kelly Koral, et al.
Hepatology (Baltimore, Md.)|July 12, 2016
Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensationShirish Paranjpe, William C Bowen, Wendy M Mars, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinaseUdayan Apte, Vasiliki Gkretsi, William C Bowen, et al.
Hepatology (Baltimore, Md.)|May 17, 2011
Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic miceChih-Wen Lin, Wendy M Mars, Shirish Paranjpe, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzeneShashikiran Donthamsetty, Vishakha S Bhave, Corrine S Kliment, et al.
Hepatology (Baltimore, Md.)|July 19, 2005
The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shockClaudio E Lagoa, Yoram Vodovotz, Donna B Stolz, et al.
The American Journal of Pathology|May 6, 2019
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced DiabetesGina M Coudriet, John Stoops, Anne V Orr, et al.
Pageof 5